Johnson & Johnson CFO On Q2 Earnings Beat

By Staff of CNBC
Tuesday, July 17, 2018 8:53 AM EDT

(Video length 00:03:55)

Joseph Wolk, Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.

 

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.